Cargando…

B cell engineering in vivo: Accelerating induction of broadly neutralizing antibodies against HIV-1 infection

Detalles Bibliográficos
Autores principales:	Sun, Caijun, Zuo, Teng, Wen, Ziyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816152/ https://www.ncbi.nlm.nih.gov/pubmed/36604417 http://dx.doi.org/10.1038/s41392-022-01269-4

Ejemplares similares

Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses
por: Cortese, Mirko, et al.
Publicado: (2021)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
por: Wilmschen, Sarah, et al.
Publicado: (2019)

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice
por: Nahmad, A. D., et al.
Publicado: (2022)

Identification and specificity of broadly neutralizing antibodies against HIV
por: McCoy, Laura E., et al.
Publicado: (2017)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
por: Kelsoe, Garnett, et al.
Publicado: (2013)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
por: Huang, Deli, et al.
Publicado: (2020)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

A broad range of themes in Microbial Biotechnology
por: Daniels, Craig, et al.
Publicado: (2009)

Designer antigens for elicitation of broadly neutralizing antibodies against HIV
por: Kok, Tuckweng, et al.
Publicado: (2014)

Induction of membraneless organelles as a strategy for HIV-1 post-nuclear entry steps
por: Zhou, Sheng, et al.
Publicado: (2023)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023)

bNAber: database of broadly neutralizing HIV antibodies
por: Eroshkin, Alexey M., et al.
Publicado: (2014)

Ontogeny‐based immunogens for the induction of V2‐directed HIV broadly neutralizing antibodies
por: Moore, Penny L., et al.
Publicado: (2017)

An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
por: Ntumngia, Francis B., et al.
Publicado: (2017)

Broadly neutralizing antibodies and vaccine design against HIV-1 infection
por: Wang, Qian, et al.
Publicado: (2019)

Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
por: Huang, Deli, et al.
Publicado: (2020)

First clinical study of germline-targeting strategy: One step closer to a successful bnAb-based HIV vaccine
por: Sun, Caijun, et al.
Publicado: (2023)

HIV vaccine development and broadly neutralizing antibodies
por: Greenspan, Neil S., et al.
Publicado: (2015)

The expanding array of HIV broadly neutralizing antibodies
por: McCoy, Laura E.
Publicado: (2018)

Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Primary African Isolates
por: Lorenzi, Julio C. C., et al.
Publicado: (2021)

Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1
por: Narayanan, Elisabeth, et al.
Publicado: (2022)

CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques
por: Sarkar, Sanghita, et al.
Publicado: (2021)

Broadly neutralizing antibodies against COVID-19
por: Zhou, Daming, et al.
Publicado: (2023)

Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV
por: Conti, Simone, et al.
Publicado: (2022)

Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV
por: Powell, Allison B., et al.
Publicado: (2020)

Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody
por: Meijers, Matthijs, et al.
Publicado: (2021)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018)

Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Engineered mice and B cell lines expressing broadly neutralizing antibodies and their unmutated precursors: tools for HIV vaccinology
por: Nemazee, D, et al.
Publicado: (2012)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1
por: Yu, Lei, et al.
Publicado: (2014)

Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response
por: Shcherbakov, D. N., et al.
Publicado: (2015)

Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
por: Zhou, Panpan, et al.
Publicado: (2019)

Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
por: Yasugi, Mayo, et al.
Publicado: (2013)

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
por: Pinto, Dora, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cuv8d2m8ffhqued03m2ortjblo